Design of a basigin-mimicking inhibitor targeting the malaria invasion protein RH5.


Journal

Proteins
ISSN: 1097-0134
Titre abrégé: Proteins
Pays: United States
ID NLM: 8700181

Informations de publication

Date de publication:
01 2020
Historique:
received: 28 02 2019
revised: 02 07 2019
accepted: 12 07 2019
pubmed: 22 7 2019
medline: 25 9 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

Many human pathogens use host cell-surface receptors to attach and invade cells. Often, the host-pathogen interaction affinity is low, presenting opportunities to block invasion using a soluble, high-affinity mimic of the host protein. The Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) provides an exciting candidate for mimicry: it is highly conserved and its moderate affinity binding to the human receptor basigin (K

Identifiants

pubmed: 31325330
doi: 10.1002/prot.25786
pmc: PMC6904230
mid: EMS83783
doi:

Substances chimiques

Carrier Proteins 0
Protozoan Proteins 0
RH5 protein, Plasmodium falciparum 0
Basigin 136894-56-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-195

Subventions

Organisme : European Research Council
ID : 815379
Pays : International
Organisme : Wellcome Trust
ID : 100993/Z/13/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106917/Z/15/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107366/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K501281/1
Pays : United Kingdom

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Cell. 2012 Mar 16;148(6):1271-83
pubmed: 22424234
Methods Enzymol. 2013;523:1-19
pubmed: 23422423
Nat Methods. 2010 Sep;7(9):741-6
pubmed: 20711194
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8705-10
pubmed: 27436899
PLoS Pathog. 2012;8(11):e1002991
pubmed: 23144611
J Struct Biol. 2010 Oct;172(1):34-44
pubmed: 20600952
J Chem Theory Comput. 2015 Feb 10;11(2):609-22
pubmed: 25866491
PLoS One. 2011;6(6):e20161
pubmed: 21731610
J Mol Biol. 1999 Feb 5;285(5):2177-98
pubmed: 9925793
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):998-1002
pubmed: 28096331
Annu Rev Biochem. 2018 Jun 20;87:105-129
pubmed: 29401000
Mol Cell. 2018 Oct 4;72(1):178-186.e5
pubmed: 30270109
BMC Biotechnol. 2008 Dec 04;8:91
pubmed: 19055817
Cell Host Microbe. 2015 Jan 14;17(1):130-9
pubmed: 25590760
Trends Parasitol. 2016 Apr;32(4):284-295
pubmed: 26778295
Nature. 2011 Nov 09;480(7378):534-7
pubmed: 22080952
Nature. 2019 Jan;565(7737):118-121
pubmed: 30542156
Mol Cell. 2018 Apr 19;70(2):380
pubmed: 29677494
Nature. 2014 Nov 20;515(7527):427-30
pubmed: 25132548
Nature. 2012 Jul 19;487(7407):375-9
pubmed: 22722859
Malar J. 2010 Jun 03;9:152
pubmed: 20525251
Nat Protoc. 2006;1(2):755-68
pubmed: 17406305
Nat Commun. 2018 Dec 11;9(1):5286
pubmed: 30538236
J Immunol. 2014 Jan 1;192(1):245-58
pubmed: 24293631
Elife. 2016 Jan 29;5:null
pubmed: 26824389
Elife. 2014 Oct 08;3:null
pubmed: 25296023
JCI Insight. 2017 Nov 2;2(21):
pubmed: 29093263
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14378-83
pubmed: 20660744
Nat Commun. 2011 Dec 20;2:601
pubmed: 22186897
Vaccine. 2013 Jan 2;31(2):373-9
pubmed: 23146673
Methods. 2017 Jan 1;112:157-166
pubmed: 27350362
Science. 2011 May 13;332(6031):816-21
pubmed: 21566186
Nat Biotechnol. 2012 May 27;30(6):543-8
pubmed: 22634563
Nat Protoc. 2007;2(1):1-4
pubmed: 17401330
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Curr Opin Struct Biol. 2013 Dec;23(6):903-10
pubmed: 23993666
Int J Parasitol. 2009 Feb;39(3):371-80
pubmed: 19000690
Vaccine. 2015 Dec 22;33(52):7433-43
pubmed: 26458807
Q Rev Biophys. 2014 Nov;47(4):285-363
pubmed: 25225856

Auteurs

Shira Warszawski (S)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Elya Dekel (E)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Ivan Campeotto (I)

Department of Biochemistry, University of Oxford, Oxford, UK.

Jennifer M Marshall (JM)

Jenner Institute, University of Oxford, Oxford, UK.

Katherine E Wright (KE)

Department of Life Sciences, Imperial College London, Sir Alexander Fleming Building, London, UK.

Oliver Lyth (O)

Department of Life Sciences, Imperial College London, Sir Alexander Fleming Building, London, UK.

Orli Knop (O)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Neta Regev-Rudzki (N)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Matthew K Higgins (MK)

Department of Biochemistry, University of Oxford, Oxford, UK.

Simon J Draper (SJ)

Jenner Institute, University of Oxford, Oxford, UK.

Jake Baum (J)

Department of Life Sciences, Imperial College London, Sir Alexander Fleming Building, London, UK.

Sarel J Fleishman (SJ)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH